Skip to main content

Table 3 Estimated duration of lead time of lung cancer detected by sputum cytology (SC) in patients with normal chest radiography (CR). The prevalenceand incidence of lung cancers detected by SC alone in persons with normal CR were derived from the data reported by the authors

From: Duration of lead time in screening for lung cancer

Trial and authors

Study population (n)

Prevalence of squamous cell cancers per 1000 at T0

Average duration of screening (years)

Average annual incidence of confirmed squamous cell lung cancers per 1000 during screening

Lead time (years)

Intervention

Control

Intervention detected by SC alone (a)

Control detected by SC alone (b)

 

Intervention, detected by SC alone (c)

Intervention, interval cancers (d)

Control, CR- detected cancers (e)

Control, interval cancers (f)

a/(c + d)

a/(e + f)

Mayo lung project: Fontana et al. 1984 [8], 1991[9]a

4618

4593

1.8

6

0.7

0.6*

Not applicable

1.0*

1.3

1.8

 

John Hopkins study: Frost et al. 1984 [10]; Doria-Rose et al. 2009 [11]b

5226

5161

2.1

Not applicable

7.2

0.9

0.5

0.8

0.9

1.5

1.2

Memorial Sloan Kettering: Melamed et al. 1984 [12]; Doria-Rose et al. 2009 [11]b

4968

5072

1.8

Not applicable

7.2

0.8

0.4

0.7

0.8

1.5

1.2

  1. aSmokers aged more than 45 years. Intervention: annual CR and sputum cytology every 4 months. Control: Advised to have annual chest radiography and sputum cytology. Intervention and control groups had CR and SC at T0. The prevalence and incidence of lung cancers detected by SC only were derived from published data.
  2. bSame as A, except that the controls were offered annual chest radiography.
  3. *Derived from authors' data indicating that 33% of all incidence cancers in the intervention and control group were squamous cell cancers